Latest Insider Transactions at Prothena Corp Public LTD CO (PRTA)
This section provides a real-time view of insider transactions for Prothena Corp Public LTD CO (PRTA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of PROTHENA CORP PUBLIC LTD CO to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of PROTHENA CORP PUBLIC LTD CO's insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jan 13
2016
|
Karin L Walker Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+50.0%
|
$76,000
$19.78 P/Share
|
Jan 04
2016
|
Arthur W Homan Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
3,125
-69.95%
|
$203,125
$65.51 P/Share
|
Jan 04
2016
|
Arthur W Homan Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,125
+50.0%
|
$68,750
$22.14 P/Share
|
Dec 09
2015
|
Tran Nguyen Chief Strategy Officer and CFO |
SELL
Open market or private sale
|
Direct |
30,000
-52.1%
|
$1,980,000
$66.28 P/Share
|
Dec 09
2015
|
Tran Nguyen Chief Strategy Officer and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+48.23%
|
$180,000
$6.73 P/Share
|
Dec 09
2015
|
Gene G. Kinney President and CEO |
SELL
Open market or private sale
|
Direct |
30,000
-46.96%
|
$1,980,000
$66.29 P/Share
|
Dec 09
2015
|
Gene G. Kinney President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+47.78%
|
$180,000
$6.41 P/Share
|
Dec 09
2015
|
Tara Nickerson Chief Business Officer |
SELL
Open market or private sale
|
Direct |
10,000
-39.22%
|
$660,000
$66.25 P/Share
|
Dec 09
2015
|
Tara Nickerson Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+45.45%
|
$60,000
$6.73 P/Share
|
Dec 01
2015
|
Dennis J. Selkoe |
SELL
Open market or private sale
|
Direct |
3,125
-21.13%
|
$215,625
$69.0 P/Share
|
Dec 01
2015
|
Dennis J. Selkoe |
BUY
Exercise of conversion of derivative security
|
Direct |
3,125
+34.36%
|
$50,000
$16.42 P/Share
|
Nov 27
2015
|
Christopher S Henney Director |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$375,000
$75.0 P/Share
|
Nov 27
2015
|
Christopher S Henney Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$30,000
$6.65 P/Share
|
Nov 25
2015
|
Lars Ekman |
SELL
Open market or private sale
|
Direct |
30,000
-75.93%
|
$2,190,000
$73.71 P/Share
|
Nov 25
2015
|
Lars Ekman |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+49.8%
|
$180,000
$6.41 P/Share
|
Nov 19
2015
|
Dale B. Schenk President and CEO |
BUY
Bona fide gift
|
Indirect |
3,333
+18.3%
|
-
|
Nov 19
2015
|
Dale B. Schenk President and CEO |
SELL
Bona fide gift
|
Direct |
3,333
-100.0%
|
-
|
Nov 17
2015
|
Dale B. Schenk President and CEO |
SELL
Open market or private sale
|
Direct |
30,000
-33.23%
|
$2,010,000
$67.7 P/Share
|
Nov 17
2015
|
Dale B. Schenk President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
33,333
+50.0%
|
$199,998
$6.03 P/Share
|
Nov 13
2015
|
Martin Koller Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
30,000
-100.0%
|
$1,950,000
$65.03 P/Share
|
Nov 13
2015
|
Martin Koller Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+50.0%
|
$180,000
$6.73 P/Share
|
Nov 02
2015
|
Arthur W Homan Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
3,125
-100.0%
|
$162,500
$52.14 P/Share
|
Nov 02
2015
|
Arthur W Homan Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,125
+50.0%
|
$68,750
$22.14 P/Share
|
Oct 29
2015
|
Christopher S Henney Director |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$275,000
$55.0 P/Share
|
Oct 29
2015
|
Christopher S Henney Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$30,000
$6.65 P/Share
|
Sep 09
2015
|
Tara Nickerson Chief Business Officer |
SELL
Open market or private sale
|
Direct |
10,000
-40.65%
|
$560,000
$56.51 P/Share
|
Sep 09
2015
|
Tara Nickerson Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+45.45%
|
$60,000
$6.41 P/Share
|
Sep 02
2015
|
Martin Koller Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,400
-100.0%
|
$297,000
$55.17 P/Share
|
Sep 02
2015
|
Martin Koller Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,400
+50.0%
|
$32,400
$6.73 P/Share
|
Sep 01
2015
|
Dennis J. Selkoe |
SELL
Open market or private sale
|
Direct |
3,125
-30.0%
|
$171,875
$55.32 P/Share
|
Sep 01
2015
|
Dennis J. Selkoe |
BUY
Exercise of conversion of derivative security
|
Direct |
3,125
+34.36%
|
$50,000
$16.42 P/Share
|
Sep 01
2015
|
Martin Koller Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
24,600
-94.0%
|
$1,353,000
$55.88 P/Share
|
Sep 01
2015
|
Martin Koller Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
24,600
+50.0%
|
$147,600
$6.73 P/Share
|
Sep 01
2015
|
Arthur W Homan Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
3,125
-67.6%
|
$171,875
$55.31 P/Share
|
Sep 01
2015
|
Arthur W Homan Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,125
+50.0%
|
$68,750
$22.14 P/Share
|
Aug 31
2015
|
Dale B. Schenk President and CEO |
BUY
Bona fide gift
|
Indirect |
3,333
+22.4%
|
-
|
Aug 31
2015
|
Dale B. Schenk President and CEO |
SELL
Bona fide gift
|
Direct |
3,333
-100.0%
|
-
|
Aug 20
2015
|
Dale B. Schenk President and CEO |
SELL
Open market or private sale
|
Direct |
30,000
-50.85%
|
$1,680,000
$56.71 P/Share
|
Aug 20
2015
|
Dale B. Schenk President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
33,333
+50.0%
|
$199,998
$6.03 P/Share
|
Aug 12
2015
|
Karin L Walker Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
7,000
-76.41%
|
$434,000
$62.24 P/Share
|
Aug 12
2015
|
Karin L Walker Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,000
+50.0%
|
$133,000
$19.78 P/Share
|
Aug 07
2015
|
Christopher S Henney Director |
SELL
Open market or private sale
|
Direct |
10,000
-75.14%
|
$630,000
$63.21 P/Share
|
Aug 07
2015
|
Christopher S Henney Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+50.0%
|
$60,000
$6.41 P/Share
|
Jun 09
2015
|
Tara Nickerson Chief Business Officer |
SELL
Open market or private sale
|
Direct |
12,000
-61.99%
|
$528,000
$44.68 P/Share
|
Jun 09
2015
|
Tara Nickerson Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,000
+46.15%
|
$72,000
$6.41 P/Share
|
Jun 01
2015
|
Dennis J. Selkoe |
SELL
Open market or private sale
|
Direct |
3,125
-21.5%
|
$121,875
$39.54 P/Share
|
Jun 01
2015
|
Dennis J. Selkoe |
BUY
Exercise of conversion of derivative security
|
Direct |
3,125
+34.36%
|
$50,000
$16.42 P/Share
|
Mar 20
2015
|
Tara Nickerson Chief Business Officer |
SELL
Open market or private sale
|
Direct |
13,000
-86.67%
|
$507,000
$39.99 P/Share
|
Mar 20
2015
|
Tara Nickerson Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,000
+46.43%
|
$78,000
$6.41 P/Share
|
Mar 09
2015
|
Dennis J. Selkoe |
SELL
Open market or private sale
|
Direct |
3,125
-52.35%
|
$78,125
$25.56 P/Share
|